Carolina Muriel López

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

Khaldoun Almhanna, David Wright, T. Macarulla Mercadé et al. · Investigational New Drugs · 2017 · 35 citations

Medicine, Oncology, Pharmacology +17

Prognostic Factors in Patients With Advanced Renal Cell Carcinoma

Carolina Muriel López, Emilio Esteban, José Pablo Berros et al. · Clinical Genitourinary Cancer · 2012 · 34 citations · Full text

Medicine, Oncology, Genitourinary Oncology +10

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C

Khaldoun Almhanna, María Luisa Limón Mirón, David Wright et al. · Investigational New Drugs · 2017 · 23 citations

Medicine, Oncology, Pharmacology +17

Predictive factors for response to treatment in patients with advanced renal cell carcinoma

Carolina Muriel López, Emilio Esteban, Aurora Astudillo et al. · Investigational New Drugs · 2012 · 21 citations

Medicine, Oncology, Chemotherapy +13

Pharmacokinetics of furosemide in thoroughbred horses subjected to supramaximal treadmill exercise with and without controlled access to water

Nicolás F. Villarino, Carolina Muriel López, Richard A. Sams et al. · BMC Veterinary Research · 2019 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13